Elan Grants Prialt™ Rights to Eisai
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 69 (Table of Contents)
Published: 6 Mar-2006
DOI: 10.3833/pdr.v2006.i69.549 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Elan sold the European rights of Prialt™ (ziconotide), a synthetic marine snail venom peptide to Eisai...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS